Red Blood Cell Precursor Formulation to Determine Increased Production

NCT01701531 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Funding not received

Conditions

Anemia

Interventions

DRUG: RBCPF

Sponsor

Targeted Medical Pharma